SEC Form 4 · accession 0000899243-18-020523
scPharmaceuticals Inc. · SCPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Minnie Baylor-Henry
Director
Period of report
Jul 20, 2018
Accepted (ET)
Jul 24, 2018 · 5:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001604950
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $4.80 | Jul 20, 2018 | A | 12,248 | A | — | Jul 20, 2028 | Common Stock | 12,248 | 12,248 | D |
Explanation of responses
- F133% of such stock option shall vest on the first anniversary of the grant date, and the remainder shall vest in equal monthly installments over the following two year period.